APPLICATIONS PUBLISHED 22 OCTOBER 2003
Published: 1-Mar-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Pharmaceutical compsns of a non-enteric coated proton pump inhibitor with a carbamate salt and a bicarbonate salt combination
TAP Pharmaceutical Products 1353624*
Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
Salus Pharma 1353647*
Microparticles of biodegradable polymer encapsulating a biologically active substance
Debio Recherche Pharmaceutique 1353648*
Personal medication dispensing card
Bassinson, Oscar 1353649*
Process for preparing non-hygroscopic sodium valproate compsn
Taro Pharmaceutical Industries; Taro Pharmaceuticals 1353650*
Extended release pharmaceutical compsns containing beta-lactam antibiotics
Natco Pharma 1353651*
Pharmaceutical tablet comprising paroxetine mesylate
Synthon 1353652*
Chewing gums and related products that provide breath-freshening characteristics
WM Wrigley 1353653*
Devices and methods for heat-pulse assisted thermal applications of active substances
LTS Lohmann Therapie-Systeme 1353654*
Method of treatment of neurodegenerative disorders using pentaaza-macrocyclic ligand complexes
Metaphore Pharmaceuticals 13536555*
Method for treating stress or tension
Orion Corp 1353656*
Histamine H4 receptor antagonists
Pfizer 1353657*
Regulation of organic nitrate tolerance
Parker, John 1353658*
Use of neurotoxic substances in producing a medicament for treating joint pain
Mestex 1353659*
Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
Gruenenthal 1353660*
Use of an LTB4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes
Boehringer Ingelheim 1353661*
Methods for the treatment of diseases using malonyl-CoA decarboxylase inhibitors
Chugai Seiyaku KK 1353662*
Fenofibrate tablets
Laboratoires Fournier 1353663*
Heterocycle derivatives and methods of use for treating anthrax infection
Board of Regents, the University of Texas System; Peterson, Johnny W; Gessell-Lee, Deborah L; Saini, Shamsher 1353664*
Treatment of depression
The McLean Hospital Corp 1353665*
Myeloperoxidase, a risk indicator for coronary heart disease
The Cleveland Clinic Foundation 1353666*
Parenteral formulations containing epothilone analogues
Bristol-Myers Squibb 1353667*
Methods of administering epothilone analogues for the treatment of cancer
Bristol-Myers Squibb 1353668*
Method for treating glaucoma IB
Alteon 1353669*
Use of chromanes
Bayer 1353670*
Neurotrophic tacrolimus analogues
Fujisawa Pharmaceuticals 1353671*
Synthesis of 3-amino-thalidomide and its enantiomers
The Children's Medical Centre 1353672*
Camptothecin derivatives
California Pacific Medical Centre 1353673*
Method for treating glaucoma IVB
Alteon 1353674
New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
Pharmacia & Upjohn 1353675*
Method for treating fibrotic diseases or other indications
Alteon 1353676*
Method of treatment of type I diabetes with vitamin D compounds
Wisconsin Alumni Research Foundation 1353677*
Method of alleviating syndromes and conditions of discomfort of the mammalian intestinal and genito-urinary tracts
Akpharma 1353678*
Compsns, methods and apparatuses for singlet oxygen delivery
Howes, Randolph 1353679*
Use of SLP1 for treating chronic inflammatory intestinal diseases
Vivotec Biomedical Technologies 1353680*
Bifidobacteria capable of preventing diarrhoea
Societe des Produits Nestle 1353681*
Method for obtaining an isolated extract of the plant Cyclamen europaeum L and its use as a therapeutic agent
Hartington Business 1353682*
Use of inhibitors of dipeptidypeptidase IV (EC 3.3.14.5) and aminopeptidase N (EC 3.4.11.2) for the treatment of neurodegeneration induced by ischaemia
Keyneutrotek 1353684*
Controlled release pharmaceuticals
PBL Biomedical Laboratories 1353685*
MHC class 1 associated peptides for prevention and treatment of tuberculosis
Argonex Pharmaceuticals 1353686*
Methods for obtaining inhibitors of TIRC7 ligand binding and its uses thereof
Utku, Nalan 1353687*
Method and compsns for immunisation with the Pseudomonas V antigen
MCW Research Foundation 1353688*
Immunising compsns and methods of use
Willmar Poultry Co 1353689*
Non-glycosylated peptides derived from the RSV G protein and use thereof in a vaccine
Pierre Fabre Medicament 1353690*
Molecular antigen array presenting amyloid beta
Cytos Biotechnology 1353691*
Method and compsns for treatment of ocular neovascularisation and neural injury
Allergan 1353692*
Pharmaceutical combination containing a 4-quinasolineamine and another antineoplastic agent for the treatment of cancer
Glaxo Group 1353693*
